does tirzepatide cause blood clots Clots? UK Evidence Review Can Tirzepatide Cause Heart Palpitations?

Patients should contact their healthcare provider promptly if they experience: Severe, persistent abdominal pain that worsens or differs from typical bloating Inability to pass gas or have bowel movements (possible obstruction) Persistent vomiting that prevents adequate hydration or medication adherence Unintentional weight loss beyond expected therapeutic effects Blood in stool or black, tarry stools Fever accompanying gastrointestinal symptoms Right upper quadrant pain or yellowing of skin/eyes (possible gallbladder disease) Severe constipation with abdominal distension (possible ileus/obstruction) Signs of dehydration (excessive thirst, dark urine, dizziness) These symptoms may indicate complications such as pancreatitis, gallbladder disease, bowel obstruction, or acute kidney injuryall noted in FDA prescribing information as potential risks

You will continue to receive/inject weekly shots, but the dosage will be increased after months 1, 2, and 3

1 2 3 "Semaglutide seven: Indian drug companies launch cheaper GLP-1s", Chemist + Druggist website , archived from the original on 15 May 2026 "NATCO, Eris to launch semaglutide generic at 90% discount in India", ETPharma.com , The Economic Times, 20 March 2026, archived from the original on 15 May 2026 "Mankind Pharma targets early Semaglutide launch", The Economic Times website , archived from the original on 15 March 2026 1 2 3 "Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China"

GLP-1 Peptide Therapy refers to the use of GLP-1 receptor agonists that: Enhance satiety by slowing gastric emptying Suppress postprandial glucagon secretion Promote insulin secretion in a glucose-dependent manner Reduce caloric intake and support sustained weight loss GLP-1 Peptide Therapy has proven to be effective for chronic weight management in adults with obesity or overweight with related comorbidities